Precision Approaches to Treat Mantle Cell Lymphoma: Integrating Multi-omics Based Models
Precision Approaches to Treat Mantle Cell Lymphoma: Integrating Multi-omics Based Models
批准号:
10530111
负责人:
Holly Ann Hill
金额:
$3.47万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-08-01 至 2023-05-31
关键词:
AffectAgeAlcohol consumptionAreaBiologicalBiological AssayCCND1 geneCDKN2A geneCancer PatientCharacteristicsClinicalClinical ResearchComputer softwareComputing MethodologiesCorrelative StudyDNADNA sequencingDataData SetDatabasesDiagnosticDiseaseDisease ProgressionDisease stratificationDrug TargetingEnvironmental ExposureEpigenetic ProcessFrequenciesFunctional disorderGene ExpressionGene Expression ProfileGenesGenetic HeterogeneityGenetic TranscriptionGenomeGenomic InstabilityGenomicsGleanHematopoiesisHollyIndividualInvestigationKnowledgeLaboratoriesLinkMalignant NeoplasmsMantle Cell LymphomaMeasurementMeta-AnalysisMethodsModelingMolecularMolecular AbnormalityMorphologyMutateMutationMutation AnalysisNOTCH1 geneNon-Hodgkin&aposs LymphomaOther GeneticsOutcomeOutputPathway AnalysisPathway interactionsPatientsPatternPharmaceutical PreparationsPhasePrecision Medicine InitiativePrecision medicine trialPrevalencePrincipal Component AnalysisPrognosisRaceRadiation exposureRelapseReportingResearchResearch Project GrantsResistanceSample SizeSamplingSingle Nucleotide PolymorphismSmokingStatistical ModelsTP53 geneTechniquesThe Cancer Genome AtlasTranslatingUniversity of Texas M D Anderson Cancer CenterVariantanalytical methodbasecancer typecircular RNAclinical investigationclinically relevantcomplex biological systemscomputerized toolsdifferential expressionepigenomicsexome sequencingfeature selectiongenetic analysisgenome sequencingimprintindividual patientinnovationinsightlifestyle factorsliquid biopsymultiple omicsmutational statusnext generation sequencingnovelpersonalized approachpersonalized medicinepersonalized therapeuticpre-doctoralprognosticprognostic of survivalresponsesexsurvival outcometargeted treatmenttherapy resistanttranscriptome sequencingtranscriptomicstreatment responsetumor DNAtumor microenvironmentwhole genome
中文摘要
项目摘要
套细胞淋巴瘤(MCL)是一种罕见的,不可治愈的形式,非霍奇金淋巴瘤,这是倾向于
治疗抗性和复发。虽然罕见,但MCL在临床和遗传上都是异质性的,
由多个子类型表示。目前尚不清楚各种基因组特征如何影响临床
MCL的病程以及这些生物学方面如何导致治疗耐药性和疾病进展。它
由于MCL的罕见性和缺乏代表性,很难研究其分子特征。
癌症基因组图谱(TCGA)。此外,目前整合组学也具有挑战性。
由于来自测序和不清楚的生物学特性的大量数据,
以及单一突变和转录特征的临床相关性。研究这些也很困难
特征与人口统计学特征和其他相关的个体特征相结合。
在拟议的论文研究项目的F99阶段,冬青山将采用新颖的分析和
在MCL患者的合并分析中整合多组学数据集的计算方法。这些分析
将包括基因组学、转录组学、表观基因组学和临床疾病组学的特征。特征选择
并将酌情使用可变的减少技术。这些子分析将识别生物学
关联并生成复合变量,这些复合变量将用于单变量和多变量模型,
检查MCL的临床结果,包括药物反应和生存率。
拟议活动的KOO阶段将包括进一步调查MCL和其他癌症,
从论文项目中获得的知识(F99)。还将使用在F99阶段获得的见解
开发靶向分析,简化MCL的突变或转录谱,
有效的应用程序。系列组学测量将被整合到相关的基因组学研究中,
精密医学试验,包括液体活检或循环肿瘤DNA(ctDNA)测序。
拟议的努力将产生对浓缩和翻译数据从组学研究到
临床空间希望这项研究的结果将为适用于精准医学试验的方法提供信息
并帮助实现我们的长期目标,为癌症患者提供个性化治疗。
英文摘要
Project Summary
Mantle cell lymphoma (MCL) is a rare, incurable form of non Hodgkin lymphoma which is disposed to
therapeutic resistance and relapse. Though rare, MCL is both clinically and genetically heterogenous and
represented by multiple subtypes. It is presently unknown how various genomic features impact the clinical
course of MCL and how these biological aspects contribute to treatment resistance and disease progression. It
is difficult to study the molecular features of MCL due to its rarity and lack of representation in accessible
databases like the cancer genome atlas (TCGA). Additionally, it is currently challenging to integrate -omics
features in precision medicine initiatives due to the vast size of data from sequencing and unclear biological
and clinical relevance of singular mutational and transcriptional features. It is also difficult to study these
features in combination with demographic and other relevant individual features.
In the F99 phase of the proposed dissertation research project, Holly Hill will employ novel analytical and
computational methods to integrate multi-omics datasets in a pooled analysis of MCL patients. These analyses
will include genomics, transcriptomics, epigenomics and features of the clinical exposome. Feature selection
and variable reduction techniques will be used as appropriate. These sub-analyses will identify biological
correlates and generate composite variables which will be used in univariate and multivariate models to
examine clinical outcomes in MCL including drug response and survival.
The KOO phase of the proposed activities will include further investigations into MCL and other cancers utilizing
knowledge gained from the dissertation project (F99). Insights acquired during the F99 phase will also be used
to develop targeted assays that simplify the mutational or transcriptional profiles of MCL into clinically useful
and valid applications. Serial -omics measurements will be integrated into correlative genomics studies and
precision medicine trials which will include sequencing from liquid biopsies or circulating tumor DNA (ctDNA).
The proposed efforts will produce insights into condensing and translating data from -omics studies into the
clinical space. It is hoped that the findings of this study will inform methods suitable for precision medicine trials
and help achieve our long-term objective to personalize therapeutics for individual cancer patients.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: